✦ LIBER ✦

Plerixafor as First- and Second-Line Strategies for Autologous Stem Cell Mobilization in Patients with Non-Hodgkin's Lymphoma or Multiple Myeloma

✍ Scribed by Kevin W. Lor; Pieter J. Helmons; Helen Belew; James R. Lane; Edward D. Ball

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Plerixafor in non-Hodgkin’s lymphoma and

✍ Jan S. Moreb 📂 Article 📅 2010 🏛 PAGEPress Publications 🌐 English ⚖ 224 KB

Plerixafor and G-CSF for autologous stem

✍ Shaughnessy, P; Uberti, J; Devine, S; Maziarz, R T; Vose, J; Micallef, I; Jacobs 📂 Article 📅 2012 🏛 Nature Publishing Group 🌐 English ⚖ 268 KB

Mobilization of peripheral blood stem ce

✍ Fruehauf, S; Ehninger, G; Hübel, K; Topaly, J; Goldschmidt, H; Ho, A D; Müller, 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 136 KB

Plerixafor and Filgrastim XM02 (Tevagast

✍ Giovanna Andreola; Aleksandra Babic; Cristina Rabascio; Mara Negri; Giovanni Mar 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 141 KB

Safety and preliminary efficacy of pleri

✍ Dugan, M J; Maziarz, R T; Bensinger, W I; Nademanee, A; Liesveld, J; Badel, K; D 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 237 KB

Treatment with Plerixafor in non-Hodgkin

✍ Patrick Stiff; Ivana Micallef; Philip McCarthy; Margarida Magalhaes-Silverman; D 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 273 KB